Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.51 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.49 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.49 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.49 |
| ▸ | NOD1 | Q9Y239 | 4/20 | 0.47 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.45 |
| ▸ | RRM1 | P23921 | 1/20 | 0.45 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.43 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.43 |
| ▸ | ACHE | P22303 | 6/20 | 0.43 |
| ▸ | S1PR2 | O95136 | 2/20 | 0.43 |
| ▸ | S1PR1 | P21453 | 2/20 | 0.43 |
| ▸ | S1PR3 | Q99500 | 2/20 | 0.43 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7797320 | 0.99 | GNAI3 (0.50) | DPP7GNAI3GNAO1GNAI1NOD1 | |
| SCHEMBL7797290 | 0.99 | GNAI3 (0.50) | DPP7GNAI3GNAO1GNAI1NOD1 | |
| SCHEMBL7805597 | 0.92 | DPP7 (0.48) | DPP7GNAI3GNAO1GNAI1NOD1 | |
| SCHEMBL7804987 | 0.85 | ACHE (0.62) | DPP7GNAI3GNAO1GNAI1NOD1 | |
| SCHEMBL7804961 | 0.85 | ACHE (0.62) | DPP7GNAI3GNAO1GNAI1NOD1 | |
| SCHEMBL7797292 | 0.85 | ACHE (0.62) | DPP7GNAI3GNAO1GNAI1NOD1 | |
| SCHEMBL7803301 | 0.85 | ACHE (0.62) | DPP7GNAI3GNAO1GNAI1NOD1 | |
| SCHEMBL457464 | 0.82 | ACHE (0.57) | DPP7GNAI3GNAO1GNAI1ACHE | |
| SCHEMBL7534573 | 0.82 | ACHE (0.57) | DPP7GNAI3GNAO1GNAI1ACHE | |
| SCHEMBL9061677 | 0.81 | ACHE (0.64) | NOD1ACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20010055620-A1 | New lysine derivatives containing an Ne-alkoxy or Ne-alkenoxycarbonyl group, their preparation and their use in cosmetic, pharmaceutical, hygiene or food compositions | L'OREAL | 2001-12-27 | — | — | US | claimed |
| EP-0652209-B1 | Derivatives of N-epsilon alkoxy-or alkenoxy-carbonyl lysine, their preparation and use in cosmetic, pharmaceutical, hygiene or alimentary compositions | OREAL (FR) | 1998-04-08 | — | — | EP | claimed |
| US-20010055620-A1 | New lysine derivatives containing an Ne-alkoxy or Ne-alkenoxycarbonyl group, their preparation and their use in cosmetic, pharmaceutical, hygiene or food compositions | L'OREAL | 2001-12-27 | — | — | US | disclosed |
| US-6207173-B1 | Lysine derivatives containing an Nε-alkoxy or Nε-alkenoxycarbonyl group, their preparation and their use in cosmetic, pharmaceutical, hygiene or food compositions | L'OREAL (FR) | 2001-03-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010055620-A1 | New lysine derivatives containing an Ne-alkoxy or Ne-alkenoxycarbonyl group, their preparation and their use in cosmetic, pharmaceutical, hygiene or food compositions | DOT1L, KDM7A, JMJD6 | DPP7 2135/4885GNAI3 2915/4885GNAO1 826/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.